Epsilon Healthcare Launches Biotech Subsidiary to Expand Beyond Cannabis
Epsilon Healthcare Limited is a diversified healthcare and pharmaceuticals company listed on the Australian Securities Exchange (ASX) under the ticker EPN. Specializing in the medicinal cannabis sector, the company owns and operates manufacturing facilities in Australia focused on producing pharmaceutical-grade cannabis products.
With a strategic approach to the global healthcare market, Epsilon Healthcare has developed a portfolio of medicinal cannabis assets. Their business model centers on developing, manufacturing, and potentially distributing cannabis-based medical treatments, positioning themselves at the forefront of an emerging and innovative healthcare segment.
The company aims to leverage the growing acceptance and medical potential of cannabis-derived treatments, targeting various healthcare applications. By investing in research, development, and manufacturing capabilities, Epsilon Healthcare seeks to establish itself as a significant player in the medicinal cannabis industry, with a particular focus on creating high-quality, pharmaceutical-grade cannabis products for therapeutic use.